Johnson & Johnson has launched its "Dual control" campaign in Asia Pacific, aiming to empower patients with inflammatory bowel disease (IBD) to manage their condition while pursuing life goals.
A 35-year-old male with Crohn’s disease (CD) presents with diarrhea, frequent abdominal cramps, and fatigue. He is on a tumor necrosis factor-alpha (TNF-α) inhibitor, infliximab 5 mg/kg infusion every ...
News Medical on MSN
Novel antibiotic targets IBD—and AI predicted how it would work before scientists could prove it
Researchers at McMaster University and the Massachusetts Institute of Technology (MIT) have made two scientific breakthroughs ...
GlobalData on MSN
McMaster University and MIT discover new antibiotic for IBD
Discovered at McMaster, the newly identified antibiotic presents a potential new therapy for individuals living with Crohn's ...
A Cerulli report puts numbers to the channel's transformation. We have resources for advisors who want to better understand ...
Investor's Business Daily on MSN
V2X Sees IBD RS Rating Climb To 74
V2X VVX had its Relative Strength (RS) Rating upgraded from 70 to 74 Wednesday — a welcome improvement, but still shy of the 80 or higher score you prefer to see. Please watch the video at ...
Investor's Business Daily on MSN
IBD 50 Stocks To Watch: Gold Miner Harmony Attempts To Clear Latest Buy Point
Harmony stock boasts a topflight 99 IBD Composite Rating, according to IBD Stock Checkup. That makes the gold stock leader one of the best names to watch in the ongoing stock market rally. With IBD's ...
Since 2008, Brielle has been crafting video game guides with an obsessive eye for detail and a style that's both approachable and thorough. Her experience in both content creation and online gaming ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback